Immunogenicity of poxvirus vector avian influenza vaccines in muscovy and pekin ducks

Avian Diseases

Volumn 54, Issue SUPPL. 1, 2010, Pages 232-238

  Bublot, Michel ^a   Richard Mazet, Alexandra ^a   Chanavat Bizzini, Sandrine ^a   Le Gros, François Xavier ^a   Duboeuf, Michelle ^a   Stoll, Anna ^b   Palfi, Vilmos ^c   Niqueux, Eric ^d   Guionie, Olivier ^d   Dren, Nick ^b  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Veterinary Medical Research Institute Hungarian Academy of Science   (Hungary)

^c CENTRAL VETERINARY INSTITUTE   (Hungary)

^d Healthy Pigs Production and Experimentation Section   (France)

Author keywords

Avian influenza; Fowlpox; Immunogenicity; Muscovy ducks; Pekin ducks; Poxvirus vector; Vaccine

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; RECOMBINANT VACCINE;

ANIMAL; AVIAN INFLUENZA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ADMINISTRATION; DUCK; FEMALE; FOWLPOX VIRUS; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; TIME;

ANIMALS; AVIPOXVIRUS; DRUG ADMINISTRATION SCHEDULE; DUCKS; FEMALE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; TIME FACTORS; VACCINES, INACTIVATED; VACCINES, SYNTHETIC;

ANAS; ANAS PLATYRHYNCHOS; AVES; CAIRINA MOSCHATA; GALLUS GALLUS; POXVIRIDAE;

EID: 77950255005     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/8795-040109-ResNote.1     Document Type: Conference Paper

References (30)

1. Alexander, D. J. A review of avian influenza in different bird species. Vet. Microbiol. 74:3-13. 2000.
2. Beato, M. S., A. Toffan, R. De Nardi, A. Cristalli, C. Terregino, G. Cattoli, and I. Capua. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine 25:4064-4072. 2007.
3. Bublot, M., K. Karaca, J. Minke, N. Pritchard, F. X. Le Gros, H. Poulet, J. C. Audonnet, D. Swayne, and B. Nordgren. Current influenza vaccines for poultry and other animal species. In: Immunobiology of influenza infection: approaches for an emerging zoonotic disease. R. A. Tripp, ed. Research Signpost, Kerala, India. pp. 117-136. 2008.
4. Bublot, M., N. Pritchard, J. S. Cruz, T. R. Mickle, P. Selleck, and D. E. Swayne. Efficacy of a fowlpox-vectored avian influenza H5 vaccine against Asian H5N1 highly pathogenic avian influenza virus challenge. Avian Dis. 51:498-500. 2007.
5. Bublot, M., N. Pritchard, D. E. Swayne, P. Selleck, K. Karaca, D. L. Suarez, J. C. Audonnet, and T. R. Mickle. Development and use of fowlpox vectored vaccines for avian influenza. Ann. N. Y. Acad. Sci. 1081:193-201. 2006.
6. Cherbonnel, M., J. Lamande, C. Allee, A. Schmitz, K. Ogor, G. Le Gall-Recule, M. O. Le Bras, C. Guillemoto, I. Pierre, J. P. Picault, and V. Jestin. Virologic findings in selected free-range mule duck farms at high risk for avian influenza infection. Avian Dis. 51:408-413. 2007.
7. Gilbert, M., X. Xiao, P. Chaitaweesub, W. Kalpravidh, S. Premashthira, S. Boles, and J. Slingenbergh. Avian influenza, domestic ducks and rice agriculture in Thailand. Agric. Ecosyst. Environ. 119:409-415. 2007.
8. Gilbert, M., X. Xiao, D. U. Pfeiffer, M. Epprecht, S. Boles, C. Czarnecki, P. Chaitaweesub, W. Kalpravidh, P. Q. Minh, M. J. Otte, V. Martin, and J. Slingenbergh. Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia. Proc. Natl. Acad. Sci. U. S. A. 105: 4769-4774. 2008.
9. Hulse-Post, D. J., K. M. Sturm-Ramirez, J. Humberd, P. Seiler, E. A. Govorkova, S. Krauss, C. Scholtissek, P. Puthavathana, C. Buranathai, T. D. Nguyen, H. T. Long, T. S. Naipospos, H. Chen, T. M. Ellis, Y. Guan, J. S. Peiris, and R. G. Webster. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc. Natl. Acad. Sci. U. S. A. 102:10682-10687. 2005.
10. Karaca, K., D. E. Swayne, D. Grosenbaugh, M. Bublot, A. Robles, E. Spackman, and R. Nordgren. Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats. Clin. Diagn. Lab. Immunol. 12:1340-1342. 2005.
11. Kim, J. K., P. Seiler, H. L. Forrest, A. M. Khalenkov, J. Franks, M. Kumar, W. B. Karesh, M. Gilbert, R. Sodnomdarjaa, B. Douangngeun, E. A. Govorkova, and R. G. Webster. Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J. Virol. 82:11374-11382. 2008.
12. Kyriakis, C. S., A. De Vleeschauwer, F. Barbé, M. Bublot, and K. Van Reeth. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Vaccine 27:2258-2264. 2009.
13. Lundqvist, M. L., D. L. Middleton, C. Radford, G. W. Warr, and K. E. Magor. Immunoglobulins of the non-galliform birds: antibody expression and repertoire in the duck. Dev. Comp. Immunol. 30:93-100. 2006.
14. Middleton, D., J. Bingham, P. Selleck, S. Lowther, L. Gleeson, P. Lehrbach, S. Robinson, J. Rodenberg, M. Kumar, and M. Andrew. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virology 359:66-71. 2007.
15. Minke, J. M., L. Fischer, P. Baudu, P. M. Guigal, T. Sindle, J. A. Mumford, and J. C. Audonnet. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Vet. Immunol. Immunopathol. 111:47-57. 2006.
16. Paoletti, E. Applications of pox virus vectors to vaccination: an update. Proc. Natl. Acad. Sci. U. S. A. 93:11349-11353. 1996.
17. Paoletti, E., J. Taylor, B. Meignier, C. Meric, and J. Tartaglia. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC. Dev. Biol. Stand. 84:159-163. 1995.
18. Prel, A., G. Le Gall-Recule, M. Cherbonnel, B. Grasland, M. Amelot, and V. Jestin. Assessment of the protection afforded by triple baculovirus recombinant coexpressing H5, N3, M1 proteins against a homologous H5N3 low-pathogenicity avian influenza virus challenge in Muscovy ducks. Avian Dis. 51:484-489. 2007.
19. Prel, A., G. Le Gall-Recule, and V. Jestin. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks. Avian Pathol. 37:513-520. 2008.
20. Songserm, T., R. Jam-on, N. Sae-Heng, N. Meemak, D. J. Hulse- Post, K. M. Sturm-Ramirez, and R. G. Webster. Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg. Infect. Dis. 12:575-581. 2006.
21. Steensels, M., M. Bublot, S. Van Borm, J. De Vriese, B. Lambrecht, A. Richard-Mazet, S. Chanavat-Bizzini, M. Duboeuf, F. X. Le Gros, and T. van den Berg. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 27:646-654. 2009.
22. Steensels, M., S. Van Borm, B. Lambrecht, J. De Vriese, F. X. Le Gros, M. Bublot, and T. van den Berg. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Dis. 51:325-331. 2007.
23. Sturm-Ramirez, K. M., D. J. Hulse-Post, E. A. Govorkova, J. Humberd, P. Seiler, P. Puthavathana, C. Buranathai, T. D. Nguyen, A. Chaisingh, H. T. Long, T. S. Naipospos, H. Chen, T. M. Ellis, Y. Guan, J. S. Peiris, and R. G. Webster. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J. Virol. 79:11269-11279. 2005.
24. Swayne, D. E., J. R. Beck, and T. R. Mickle. Efficacy of recombinant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Dis. 41:910-922. 1997.
25. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, and D. L. Suarez. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18:1088-1095. 2000.
26. Tian,G., S. Zhang, Y. Li, Z. Bu, P. Liu, J. Zhou, C. Li, J. Shi, K. Yu, and H. Chen. Protective efficacy in chickens, geese and ducks of an H5N1- inactivated vaccine developed by reverse genetics. Virology 341:153-162. 2005.
27. van den Berg, T., B. Lambrecht, S. Marche, M. Steensels, S. Van Borm, and M. Bublot. Influenza vaccines and vaccination strategies in birds. Comp. Immunol. Microbiol. Infect. Dis. 31:121-165. 2008.
28. van der Goot, J. A., M. van Boven, A. Stegeman, S. G. van de Water, M. C. de Jong, and G. Koch. Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology 382:91-97. 2008.
29. Webster, R. G., W. J. Bean, O. T. Gorman, T. M. Chambers, and Y. Kawaoka. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56:152-179. 1992.
30. Webster, R. G., R. J. Webby, E. Hoffmann, J. Rodenberg, M. Kumar, H. J. Chu, P. Seiler, S. Krauss, and T. Songserm. The immunogenicity and efficacy against H5N1 challenge of reverse geneticsderived H5N3 influenza vaccine in ducks and chickens. Virology 351:303-311. 2006